INPLASY202440092

Efficacy and safety of neoadjuvant therapy for HR-positive/HER2-negative early breast cancer: a Bayesian network meta-analysis

Keywords: breast cancer, chemotherapy, endocrine therapy, hormone receptor-positive/ human epidermal growth factor receptor 2-negative, immunotherapy, neoadjuvant, network meta-analysis.

Download PDF - 202440092

Review Status: completed and published